- Previous Close
0.1310 - Open
0.1160 - Bid 0.0960 x --
- Ask 0.1200 x --
- Day's Range
0.1000 - 0.1160 - 52 Week Range
0.0940 - 0.2820 - Volume
5,702 - Avg. Volume
158 - Market Cap (intraday)
30.657M - Beta (5Y Monthly) 1.70
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date Nov 21, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness, and Revibe brands. In addition, it provides management, advisory, cultivation, non-cannabis products, and dispensary services to entities in the cannabis field through operations agreements and direct sales. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona.
www.vextscience.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: VV5.F
View MorePerformance Overview: VV5.F
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VV5.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VV5.F
View MoreValuation Measures
Market Cap
27.18M
Enterprise Value
63.15M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.71
Price/Book (mrq)
0.30
Enterprise Value/Revenue
1.92
Enterprise Value/EBITDA
5.32
Financial Highlights
Profitability and Income Statement
Profit Margin
-20.80%
Return on Assets (ttm)
-7.68%
Return on Equity (ttm)
-8.68%
Revenue (ttm)
33.33M
Net Income Avi to Common (ttm)
-6.93M
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
3.39M
Total Debt/Equity (mrq)
44.21%
Levered Free Cash Flow (ttm)
15.25M